Use of natural killer cells as immunotherapy for leukaemia.
Natural killer (NK) cells potentially play a significant role in eradicating residual disease following allogeneic haematopoietic cell transplantation, and have been explored as tools for adoptive immunotherapy for chemotherapy-refractory patients. NK cell cytotoxicity is modulated by multiple activating and inhibitory receptors that maintain a balance between self-tolerance and providing surveillance against pathogens and malignant transformation. The functional characteristics of NK cells are dictated by the strength of inhibitory receptor signalling. Major histocompatibility complex (MHC)-specific inhibitory receptor acquisition occurs sequentially during NK cell development, and is determined by the nature of immunological reconstitution after allogeneic haematopoietic cell transplantation. Polymorphisms of inhibitory receptors [killer immunoglobulin-like receptors (KIRs)] and their ligands (MHC) contribute to interindividual variability. As a result, the functional NK cell repertoire of individual donors has variable potential for graft-vs-leukaemia reactions. Models predicting NK cell alloreactivity, including KIR ligand mismatch and missing KIR ligand strategies, are discussed as algorithms for optimal NK cell donor selection. Future modifications to improve NK cell adoptive immunotherapy by means of increasing target recognition and reducing inhibitory signalling are being explored.
Grzywacz
Bartosz
B
Division of Blood and Marrow Transplantation, University of Minnesota, MN, USA.
Miller
Jeffrey S
JS
Verneris
Michael R
MR
D019264:Adoptive Transfer; D015703:Antigens, CD / Q000235:genetics; D006087:Graft vs Host Reaction; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology / Q000637:transplantation*; D007938:Leukemia / Q000276:immunology* / Q000628:therapy; D008285:Major Histocompatibility Complex; D011110:Polymorphism, Genetic; D017634:Self Tolerance / Q000276:immunology; D014184:Transplantation, Homologous / Q000276:immunology
D015703:Antigens, CD
Nat Immunol. 2003 Aug;4(8):801-7
12858173
J Exp Med. 1998 Jan 5;187(1):117-22
9419217
Tissue Antigens. 2004 Mar;63(3):204-11
14989709
Blood. 2004 Mar 1;103(5):1770-8
14604968
J Exp Med. 2004 May 3;199(9):1245-54
15123744
Immunity. 1997 Dec;7(6):739-51
9430220
Blood. 2006 Feb 15;107(4):1688-95
16131570
J Exp Med. 2005 Oct 3;202(7):907-12
16203864
J Exp Med. 1971 Dec 1;134(6):1513-28
4942407
J Immunol. 2002 Mar 1;168(5):2307-15
11859120
J Exp Med. 1998 Dec 21;188(12):2375-80
9858524
J Exp Med. 2007 Jun 11;204(6):1441-51
17535975
Leukemia. 1996 Mar;10(3):478-82
8642865
Eur J Immunol. 2004 Nov;34(11):3028-38
15368269
Cell. 1986 Mar 28;44(6):849-59
2420467
J Immunol. 2002 Jul 1;169(1):239-47
12077250
Bone Marrow Transplant. 2003 Jul;32(2):177-86
12838283
Nature. 1998 Feb 19;391(6669):795-9
9486650
Blood. 2003 Dec 1;102(12):4067-75
12893752
Blood. 2006 Dec 1;108(12):3824-33
16902150
Hum Immunol. 2007 May;68(5):309-23
17462498
Blood. 2005 Dec 15;106(13):4370-6
16131567
Blood. 2002 Feb 15;99(4):1273-81
11830476
Blood. 2003 Aug 1;102(3):814-9
12689936
Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84
16864058
Biol Blood Marrow Transplant. 2007 Mar;13(3):315-28
17317585
J Exp Med. 2006 Mar 20;203(3):633-45
16533882
Nature. 1998 Feb 12;391(6668):703-7
9490415
Immunol Rev. 2006 Dec;214:73-91
17100877
J Exp Med. 1995 Mar 1;181(3):1133-44
7532677
Nature. 1980 May 29;285(5763):341-2
7374786
Annu Rev Immunol. 2001;19:291-330
11244039
J Immunol. 2007 Jul 1;179(1):89-94
17579025
Transpl Immunol. 2007 Nov;18(2):85-7
18005849
Immunol Rev. 2001 Jun;181:279-89
11513149
Nature. 1992 Jul 2;358(6381):66-70
1614533
Blood. 2002 Nov 15;100(10):3825-7
12393440
Nature. 2005 Aug 4;436(7051):709-13
16079848
Blood. 2007 Jan 1;109(1):323-30
16940427
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204
9560253
Leukemia. 2005 Dec;19(12):2215-22
16224486
Annu Rev Immunol. 1996;14:619-48
8717527
J Immunol. 2008 Jan 1;180(1):163-70
18097016
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12000-4
8265660
Nat Immunol. 2006 May;7(5):517-23
16565719
J Immunol. 1986 Nov 1;137(9):2735-9
3489775
Cancer Res. 2004 Jul 1;64(13):4664-9
15231679
J Immunol. 2007 Jul 15;179(2):854-68
17617576
J Immunol. 2005 Aug 1;175(3):1619-27
16034101
Transfusion. 2007 Mar;47(3):520-8
17319835
Blood. 2005 Mar 1;105(5):2028-35
15528315
Blood. 2007 Jul 15;110(2):578-86
17392508
J Immunol. 2003 Dec 15;171(12):6640-9
14662867
Leukemia. 2005 Aug;19(8):1446-51
15973456
Annu Rev Immunol. 2005;23:225-74
15771571
Br J Haematol. 1983 Oct;55(2):305-9
6193803
Science. 2002 Mar 15;295(5562):2097-100
11896281
Br J Cancer. 2007 Aug 20;97(4):539-42
17667923
Blood. 2007 Sep 1;110(5):1530-9
17495133
Tissue Antigens. 2005 Jun;65(6):519-28
15896199
J Immunol. 1986 Jun 15;136(12):4480-6
3086432
Nature. 1986 Feb 20-26;319(6055):675-8
3951539
J Exp Med. 2006 Apr 17;203(4):1033-43
16606675
J Immunol. 2002 Jan 1;168(1):240-52
11751968
Blood. 1999 Jul 1;94(1):333-9
10381530
J Immunol. 2005 Jan 15;174(2):727-34
15634892
Hum Immunol. 2002 Apr;63(4):271-80
12039408
Nature. 2000 Nov 2;408(6808):57-63
11081504
Semin Cancer Biol. 2006 Oct;16(5):393-403
16935000
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10332-6
1946452
Immunity. 1997 Dec;7(6):753-63
9430221
Clin Cancer Res. 2007 Jun 15;13(12):3630-6
17575227
N Engl J Med. 1987 Apr 9;316(15):889-97
3493432
Blood. 2006 Feb 1;107(3):1230-2
16239436
J Immunol. 2015 Jun 1;194(11):5044-6
25980028
Immunity. 1996 Dec;5(6):629-38
8986721
Blood. 2003 May 1;101(9):3730-40
12511415
Immunity. 2006 Aug;25(2):331-42
16901727
Immunol Rev. 2001 Jun;181:170-84
11513138
Genes Immun. 2007 Apr;8(3):245-53
17315044
J Immunol. 1979 Jul;123(1):252-8
376742
Exp Hematol. 1999 Oct;27(10):1533-41
10517495
J Immunol. 2005 Mar 1;174(5):2878-84
15728498
J Immunol. 2007 Mar 15;178(6):3918-23
17339492
J Clin Invest. 1998 May 1;101(9):1835-42
9576746
Blood. 2001 May 15;97(10):3132-7
11342440
Clin Cancer Res. 2006 Mar 15;12(6):1750-9
16551859
Br J Haematol. 2002 Jun;117(4):821-7
12060116
Blood. 2003 Aug 15;102(4):1389-96
12714493
Blood. 2005 Apr 15;105(8):3051-7
15632206
Transplantation. 2006 Oct 27;82(8):1024-30
17060849
J Exp Med. 2004 Mar 15;199(6):879-84
15007091
Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):399-409
17088643
Klin Padiatr. 2005 Nov-Dec;217(6):345-50
16307421
Blood. 2005 Jun 15;105(12):4878-84
15731175
Blood. 2001 Aug 1;98(3):705-13
11468170
Bone Marrow Transplant. 1997 May;19(9):891-7
9156262
J Immunol. 2004 Jan 1;172(1):644-50
14688377
Science. 2004 Nov 26;306(5701):1517-9
15567854
Blood. 2007 Jun 1;109(11):5058-61
17317850
Hum Immunol. 2002 Jun;63(6):444-51
12039519
Eur J Immunol. 1975 Feb;5(2):112-7
1234049
Eur J Immunol. 2001 Sep;31(9):2680-9
11536166
J Immunol. 2006 Feb 1;176(3):1582-7
16424187
Blood. 2005 Jun 1;105(11):4416-23
15728129
Mamm Genome. 1999 Feb;10(2):154-60
9922396